Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

View:
Post by bluemoons20 on Aug 09, 2021 8:57am

AGM news

I am getting the feeling that the news coming out of the AGM  is not going to be  'game changing'.

Usually, if that were the case  the  market  would be  upbeat at the open  but it seems to be flat.

I sure hope for the best.
GLTA
Comment by woundedknee on Aug 09, 2021 9:09am
Normally the news,if any, that comes out of an AGM is the election of officers and some options granted.
Comment by snuff133 on Aug 09, 2021 9:54am
Attached is today’s news release about strengthening our Intellectual Property (IP) estate and building value for the company.  As usual, here is some background:   1. The original AI (KBR) was licensed from the University of Washington for right ventricle analysis. 2. Over several years, the company improved the KBR and built better catalogues of diseased hearts to achieve ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities